Steven Cohen's ADPT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 319,471 shares of Adaptive Biotechnologies Corporation (ADPT) worth $4.78 M, representing 0.01% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ADPT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 5.66 M shares. Largest reduction occurred in Q1 2024, reducing 3.45 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2019 | +50,000 | New Buy | 50,000 | $48.30 |
| Q3 2019 | -50,000 | Sold Out | 50,000 | $0.00 |
| Q3 2023 | +5.71 M | New Buy | 5.71 M | $5.45 |
| Q4 2023 | -1.99 M | Reduce 34.85% | 3.72 M | $4.90 |
| Q1 2024 | -3.45 M | Reduce 92.62% | 274,700 | $3.21 |
| Q2 2024 | -274,700 | Sold Out | 274,700 | $0.00 |
| Q3 2024 | +495,492 | New Buy | 495,492 | $5.12 |
| Q4 2024 | +441,839 | Add 89.17% | 937,331 | $6.00 |
| Q1 2025 | -937,331 | Sold Out | 937,331 | $0.00 |
| Q2 2025 | +1.37 M | New Buy | 1.37 M | $11.65 |
| Q3 2025 | -1.05 M | Reduce 76.75% | 319,471 | $14.96 |
Steven Cohen's Adaptive Biotechnologies Corporation Investment FAQs
Steven Cohen first purchased Adaptive Biotechnologies Corporation (ADPT) in Q2 2019, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Adaptive Biotechnologies Corporation (ADPT) for 26 quarters since Q2 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q3 2023, adding 5,713,300 shares worth $31.14 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 319,471 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $4.78 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in Adaptive Biotechnologies Corporation (ADPT) was 5,713,300 shares, as reported at the end of Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.